Adenocarcinoma of the urinary bladder is a rare malignancy with a poor prognosis. Patient survival is similar to that of muscle-invasive urothelial carcinoma. [10] Unlike other cancers ...

Primary signet ring cell adenocarcinoma of the bladder accounts for less than 1 per cent of all primary bladder neoplasms. This tumor is insidious because of its subepithelial infiltrative nature ...

Armando, a 71-year-old with an active lifestyle, was midway through a round of golf when a strange sensation crept into his ...

A new report dives into the evolving clinical trial landscape and transformative therapies changing lives for bladder cancer ...

Bladder cancer is a cancer that forms in tissues of the bladder. Most bladder cancers are transitional cell carcinomas (cancer that begins in cells that normally make up the inner lining of the ...

A urinary bladder stone, also referred to as bladder calculus, is a hard mass of minerals that accumulates in the bladder. It happens when there is a buildup of urine in the bladder for a long ...

Transitional cell carcinoma (TCC) is a type of cancer that originates in the transitional epithelium, which lines the bladder and urethra in dogs. This condition is particularly concerning in ...

J&J on Wednesday said the application covers TAR-200 in Bacillus Calmette-Guerin-unresponsive high-risk non-muscle-invasive bladder cancer with carcinoma in situ, with or without papillary tumors.

TORONTO, ON / ACCESS Newswire / / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and ...